Suchergebnisse - "Lervat, Cyril"

PubPharm (5)

1

Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France

enthalten in: International journal of cancer | 2023

von Corvest, V. | Marec-Bérard, P. | Lervat, C. | +25

2

Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 Years

enthalten in: Journal of adolescent and young adult oncology | 2020

von Marec-Berard, P. | Laurence, V. | Occean, B. | +17

3

Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2018

von Gaspar, N. | Occean, B. | Pacquement, H. | +24

4

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006) : a randomised, multicentre, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2016

von Piperno-Neumann, S. | Le Deley, M. | Rédini, F. | +23

CommentIn: Lancet Oncol. 2016 Aug;17 (8):1022-1023. - PMID 27511145

5

Head and neck presentations of B-NHL and B-AL in children/adolescents : experience of the LMB89 study

enthalten in: Pediatric blood & cancer | 2014

von Lervat, C. | Auperin, A. | Patte, C. | +9

1
[1]